Incidence of type 2 diabetes mellitus and glucose abnormalities in patients with chronic hepatitis C infection by response to treatment: Results of a cohort study

American Journal of Gastroenterology

Volumn 103, Issue 10, 2008, Pages 2481-2487

  Giordanino, Chiara ^a   Bugianesi, Elisabetta ^a   Smedile, Antonina ^a   Ciancio, Alessia ^a   Abate, Maria Lorena ^a   Olivero, Antonella ^a   Pellicano, Rinaldo ^a   Cassader, Maurizio ^a   Gambino, Roberto ^a   Bo, Simona ^a   Ciccone, Giovannino ^b   Rizzetto, Mario ^a   Saracco, Giorgio ^a  

^a MOLINETTE HOSPITAL   (Italy)

^b Cancer Epidemiology Unit   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RIBAVIRIN;

ADULT; ARTICLE; CHRONIC HEPATITIS; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMPAIRED GLUCOSE TOLERANCE; INCIDENCE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK FACTOR; TREATMENT FAILURE; VIRUS LOAD;

ADULT; ANTIVIRAL AGENTS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DRUG CARRIERS; FEMALE; FOLLOW-UP STUDIES; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HEPACIVIRUS; HEPATITIS C ANTIBODIES; HEPATITIS C, CHRONIC; HUMANS; INCIDENCE; INSULIN RESISTANCE; INTERFERON ALFA-2A; ITALY; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; POLYMERASE CHAIN REACTION; PROGNOSIS; RETROSPECTIVE STUDIES; RIBAVIRIN; RISK FACTORS; RNA, VIRAL; TIME FACTORS;

EID: 53149087822     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2008.02002.x     Document Type: Article

References (25)

1. Kahn BB. Type 2 diabetes: When insulin secretion fails to compensate for insulin resistance. Cell 1998 92 : 593 6.
2. Cavaghan MK, Ehrmann DA, Polonsky KS. Interactions between insulin resistance and insulin secretion in the development of glucose intolerance. J Clin Invest 2000 106 : 329 33.
3. Mehta SH, Brancati FL, Sulkowski MS, et al. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med 2000 133 : 592 9.
4. Mason AL, Lau JY, Hoang N, et al. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999 29 : 328 33.
5. Zein CO, Levy C, Basu A, et al. Chronic hepatitis C and type II diabetes mellitus: A prospective cross-sectional study. Am J Gastroenterol 2005 100 : 48 55.
6. Hui JM, Sud A, Farrell GC, et al. Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression. Gastroenterology 2003 125 : 1695 704.
7. Kawaguchi T, Yoshida T, Harada M, et al. Irus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signalling 3. Am J Pathol 2004 165 : 1499 508.
8. Shintani Y, Fujie H, Miyoshi H, et al. Hepatitis C virus infection and diabetes: Direct involvement of the virus in the development of insulin resistance. Gastroenterology 2004 126 : 840 8.
9. Aytug S, Reich D, Sapiro LE, et al. Impaired IRS-1/PI3-kinase signalling in patients with HCV: A mechanism for increased prevalence of type 2 diabetes. Hepatology 2003 38 : 1384 92.
10. Persico M, Capasso M, Persico E, et al. Suppressor of cytokine signaling 3 (SOCS3) expression and hepatitis C virus-related chronic hepatitis: Insulin resistance and response to antiviral therapy. Hepatology 2007 46 : 1009 15.
11. Romero-Gomez M, Del Mar Viloria M, Andrade RJ, et al. Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients. Gastroenterology 2005 128 : 636 41.
12. Simò R, Lecube A, Genescà J, et al. Sustained virological response correlates with reduction in the incidence of glucose abnormalities in patients with chronic hepatitis C virus infection. Diabetes Care 2006 29 : 2462 6.
13. Saracco G, Rosina F, Torrani Cerenzia MR, et al. A randomized controlled trial of interferon alfa-2b as therapy for chronic nonAnonB hepatitis. J Hepatol 1990 11 : S43 9.
14. Saracco G, Borghesio E, Mesina P, et al. Prolonged treatment (2 years) with different doses (3 versus 6 MU) of interferon alfa-2b for chronic hepatitis type C: Results of a multicenter randomized trial. J Hepatol 1997 27 : 56 62.
15. Saracco G, Ciancio A, Olivero A, et al. A randomized 4-arm multicentre study of interferon-alfa2b plus ribavirin in the treatment of patients with chronic hepatitis C not responding to interferon alone. Hepatology 2001 34 : 133 8.
16. Saracco G, Olivero A, Ciancio A, et al. A randomized 4-arm multicenter study of interferon alfa-2b plus ribavirin in the treatment of patients with chronic hepatitis C relapsing after interferon monotherapy. Hepatology 2002 36 : 959 66.
17. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 : 412 9.
18. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995 22 : 696 9.
19. Kettaneh A, Marcellin P, Douvin C, et al. Features associated with success rate and performance of fibroscan measurements for the diagnosis of cirrhosis in HCV patients. A prospective study of 935 patients. J Hepatol 2007 46 : 628 34.
20. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2005 28 (Suppl 1 S37 42.
21. Mehta SH, Brancati FL, Strathdee SA, et al. Hepatitis C virus infection and incident type 2 diabetes. Hepatology 2003 38 : 50 6.
22. Kawaguchi T, Ide T, Taniguchi E, et al. Clearance of HCV improves insulin resistance, beta-cell function and hepatic expression of insulin receptor substrate 1 and 2. Am J Gastroenterol 2007 102 : 570 6.
23. Romero-Gomez M, Fernandez-Rodriguez CM, Andrade RJ, et al. Effect of sustained virological response to treatment on the incidence of abnormal glucose values in chronic hepatitis C. J Hepatol 2008 48 : 721 7.
24. United Kingdom Prospective Diabetes Study Group: UK Prospective Diabetes Study. V. Characteristics of newly presenting type 2 diabetic patients: Estimated insulin sensitivity and islet beta-cell function: Multicentre study. Diabet Med 1988 5 : 444 8.
25. Haffner SM, Miettinen H, Stern MP. The homeostasis model in the San Antonio Heart Study. Diabetes Care 1997 20 : 1087 92.